期刊文献+

奥沙利铂联合亚叶酸钙/氟尿嘧啶治疗晚期胃癌的临床观察 被引量:5

Oxaliplatin combined with leucovorin and 5-fluorouracil chemotherapy in treatment of advanced gastric cancer
下载PDF
导出
摘要 目的:观察奥沙利铂(L-OHP)联合亚叶酸钙(LV)、氟尿嘧啶(5-Fu)治疗晚期胃癌的近期疗效和毒副作用。方法:35例均接受L-OHP200mg静脉滴注,第1天;LV200mg/m^2静脉滴注30min,然后给予5-Fu200mg/m^2静脉推注,后续5-Fu400mg/m^2静脉滴注,第1~5天,4周重复,至少治疗2周期后判定疗效。结果:可评价疗效者34例,完全缓解2例,部分缓解14例,总有效率47.1%。可评价毒性患者34例,胃肠道反应为最主要毒副作用,其次为骨髓抑制白细胞减少、周围神经毒性。结论:L-OHP联合LV、5-Fu治疗晚期胃癌疗效较好,不良反应较轻能耐受,是晚期胃癌可供选择方案。 Objective:To explore the effects and side effects of oxaliplatin(L-OHP) combined with leucovorin (LV) and 5-fluorouracil (5-Fu) regimen on patients with advanced gastric cancer. Methods :Thirty-five patients with advanced gastric cancer were administered oxaliplatin 200 mg intravenously at day 1. LV 200 mg/m2 was infused intravenously for 1/2 hour, then 5-Fu 200 mg/m2 bolus was given,followed by 400 mg/m2 intravenous drip. The therapy lasted from day 1 - 5, and then repeated every 4 weeks. The results were evaluated after 2 cycles. Results:Of the thirty-five patients,complete response was observed in two cases and partial response in 14. The overall response rate achieved 47. 1%. The main side effects were nausea, vomiting, myelosuppression and peripheral neurotoxicity. Conclusions:Oxaliplatin combined with LV/5-Fu is highly effective and well tolerable. It is a selective regimen for patients with advanced gastric cancer.
出处 《蚌埠医学院学报》 CAS 2009年第5期417-419,共3页 Journal of Bengbu Medical College
关键词 胃肿瘤 肿瘤/药物疗法 联合 奥沙利铂 亚叶酸钙 氟尿嘧啶 stomach neoplasms neoplasms/drug therapy, comlination oxaliplatin leucovorin 5-fluorouracil
  • 相关文献

参考文献10

二级参考文献49

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2Bleiberg H. Oxaliplatin (L-OHP): a new reality in colorectal cancer [J]. BrJ Cancer, 1998, 77 (Supple 4):1-3.
  • 3Louvet C, de Gramont A. Place et interet Ⅰ' oxaliplatine dans les cancers colorectaux metastases [J]. Rev Med Interne, 1997, 18(Suppl 4) :368s - 371s.
  • 4Maindrault-Goebel F, de Gramont A, Louvet C, et al. High-dose intencity Oxaliplatin added to the simplified bimonthly leuovorin and 5-flourouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX7) [J]. Eur J Cancer, 2001,37(8):1000- 1005.
  • 5Maindrault-Goebel F, Louvet C, Andre J, et al. Oxaliplatin Added to the Simplified Bimonthly Leucovorin and 5-Flourouracil Regimen as Second-line Therapy for Metastatio Colorectal Cancer (FOLFOX6) [J]. Eur J Cancer, 1999, 35(9):1338-1342.
  • 6李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 7De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
  • 8Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
  • 9Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
  • 10De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.

共引文献974

同被引文献46

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部